SAVIENT PHARMACEUTICALS
Savient Pharmaceuticals is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXAรขโยข (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology us... ed in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA. Savient also manufactures and supplies Oxandrinรยฎ (oxandrolone tablets, USP) CIII in the U.S.
SAVIENT PHARMACEUTICALS
Industry:
Biotechnology
Founded:
1980-01-01
Address:
East Brunswick, New Jersey, United States
Country:
United States
Website Url:
http://www.savientpharma.com
Total Employee:
51+
Status:
Closed
Contact:
732-418-9300
Technology used in webpage:
Google Apps For Business Pound Sterling
Official Site Inspections
http://www.savientpharma.com
- Host name: ec2-52-7-36-219.compute-1.amazonaws.com
- IP address: 52.7.36.219
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149